Skip to main navigation Skip to search Skip to main content

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

  • Evan J. Wuthrick
  • , Mitchell Kamrava
  • , Walter J. Curran
  • , Maria Werner-Wasik
  • , Kevin A. Camphausen
  • , Terry Hyslop
  • , Rita Axelrod
  • , David W. Andrews
  • , Jon Glass
  • , Mitchell MacHtay
  • , Adam P. Dicker

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science